Researchers Call for End to Routine Lab Monitoring in Isotretinoin Patients
Source Summary
Researchers argue that clinicians should discontinue routine laboratory monitoring of liver function and lipids in patients taking isotretinoin for acne and other skin conditions. The recommendation is based on evidence showing an exceptionally low risk associated with the medication.
Why it matters
This recommendation could change clinical practice by reducing unnecessary testing burden and costs for patients on isotretinoin therapy.
